Evidence map›Paper›PMID 38074818›Full record

ArticleAmerican journal of translational research2023

Association of the

Suruchi Gupta, Indu Priya, Manu Arora, Hemender Singh, Isar Sharma, Sakshi Sharma, Ritu Mahajan, Nisha Kapoor

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. T-Cadherin (International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Suruchi GuptaSchool of Biotechnology, University of Jammu Jammu 180006, India.
Indu PriyaSchool of Biotechnology, University of Jammu Jammu 180006, India.
Manu AroraGovt Psychiatric Disease Hospital, Govt Medical College Jammu 180001, India.
Hemender SinghSchool of Biotechnology, Shri Mata Vaishno Devi University Katra 182320, India.
Isar SharmaSchool of Biotechnology, University of Jammu Jammu 180006, India.
Sakshi SharmaSchool of Biotechnology, University of Jammu Jammu 180006, India.
Ritu MahajanSchool of Biotechnology, University of Jammu Jammu 180006, India.
Nisha KapoorSchool of Biotechnology, University of Jammu Jammu 180006, India.
University of Jammu · INGovernment Medical College · INIndian Institute of Integrative Medicine · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesCadherin13 (

methodsThe genotyping was performed using TaqMan assay, where 560 individuals, comprising 164 patients and 396 healthy controls, were genotyped.

resultsThe result of the study suggested rs9940180 was significantly found to be associated with Schizophrenia and the "C" allele of rs9940180 was associated with increased risk for SCZ (P = 0.03817; OR = 1.527; 95% CI, 1.022-2.28) whereas the other variant rs7204454 of

conclusionThis is the first report suggesting a significant association of polymorphism at

Indexed as

Cadherin13genetic variantslinkage disequilibriumrs9940180Schizophrenia

Identifiers

PMID38074818
PMCPMC10703641
OpenAlexW4389800922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.